Virtu Financial LLC Soleno Therapeutics Inc Transaction History

Virtu Financial LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$0.14 - $0.23 $9,459 - $15,540	67,569 New	67,569 $12,000
Q1 2022 May 17, 2022	SELL	$0.22 - $0.47 $5,198 - $11,105	-23,628 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$0.41 - $0.91 $9,687 - $21,501	23,628 New	23,628 $10,000
Q1 2021 May 19, 2021	SELL	$1.24 - $3.3 $54,062 - $143,876	-43,599 Closed	0 $0
Q4 2020 Feb 24, 2021	SELL	$1.61 - $2.23 $27,041 - $37,455	-16,796 Reduced 27.81%	43,599 $84,000
Q3 2020 Dec 11, 2020	SELL	$1.71 - $2.51 $14,557 - $21,367	-8,513 Reduced 12.35%	60,395 $152,000
Q2 2020 Aug 07, 2020	BUY	$1.77 - $4.23 $121,967 - $291,480	68,908 New	68,908 $153,000
Q2 2019 Aug 13, 2019	SELL	$1.93 - $2.95 $67,712 - $103,497	-35,084 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$1.35 - $2.68 $47,363 - $94,025	35,084 New	35,084 $72,000
Q2 2018 Jul 30, 2018	SELL	$1.56 - $3.1 $28,314 - $56,265	-18,150 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$1.56 - $3.1 $28,314 - $56,265	18,150 New	18,150 $42,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $375M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.